← SynDRA
AZM-475271
SynDRA canonical compound SYN0006382 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SRC |
|---|
| Mechanism of action | SRC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ABL1 INHIBITOR
- Tyrosine-protein kinase ABL inhibitor
- SRC inhibitor
- Tyrosine-protein kinase SRC inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KDR
- BTK
- CSK
- FYN
- HDAC6
- LCK
- LYN
- PTK6
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- KSYK
- NSD2
- NTM1A
- NTMT1
- SYK
- TP53
Cross-references
Synonyms
- M-475271
- RefChem:154852
- DTXCID10119713
- Src Kinase Inhibitor M475271
- AZM475271
- C23H27ClN4O3
- M475271
- Methoxy Aniline 7
- UNII-0361Z8214O
- N-(2-Chloro-5-methoxyphenyl)-6-methoxy
- BDBM6198
- orb1707601
- SCHEMBL3195079
- SCHEMBL29388701
- GLXC-10377
- BUA15998
- MFCD19690925
- AZM 475271 [WHO-DD]
- AKOS024457900
- AZM475271?
- NCGC00370984-01
- NCGC00370984-02
- HY-13561
- MS-27972
- DB-158888
- F85123
- T14487
- m-475271
Look up AZM-475271 in the interactive SynDRA portal →